San Francisco Bay Area
Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Total Funding: $20M
Total Funding: $46M
Total Funding: $220
Total Funding: $45M
Total Funding: $16M
Total Funding: $10M
Total Funding: $5M
Total Funding: $250M
Total Funding: $10M
Total Funding: $36M
Total Funding: $260M
Total Funding: $60M
Total Funding: $10M
Total Funding: $240M
Total Funding: $120K
Total Funding: $740M
Total Funding: $110M
Total Funding: $2.7M
2022
‘Applied AI’ in Deep tech, Health tech, & New economy // Helping great entrepreneurs build 'century-defining' businesses & technologies.
2024
Bringing ivonescimab – a novel, first-in-class bi-specific antibody combining immunotherapy via PD-1 blockade and anti-angiogenesis via blocking VEGF in a single molecule – quickly and responsibly to clinical deployment, to help change cancer outcomes for millions of patients.
2024
2024
d-Matrix powers next generation compute for generative AI and large language models.
2022
2022
Manifold Bio is a next-generation protein therapeutics company pioneering an in-vivo biologics design platform.
2021
Zapata Computing is a quantum computing software & services company – powering quantum-enabled AI, machine learning & optimization for enterprises.
2021
2021
Upstart's mission is to enable effortless credit based on true risk, enabled by AI/ML.
2020
Mammoth Biosciences is building the CRISPR platform for the next generation of diagnostics, therapeutics, and cell/gene therapies.
2018
Openwater is creating a new generation of imaging technologies to change how we read and write our bodies and brains.
2019
2019
Genalyte is a healthcare analytics & diagnostics company improving patient outcomes with real-time point-of-care results.
2009
2009
Member of Nomination & Governance (2010-2012) and Audit (2012-present) Committees. Helped focus EA’s transition from retail to online/cloud & mobile delivery. Valuation increased 600% over tenure.